Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

170.69
+2.811.67%
Post-market: 170.65-0.0400-0.02%19:30 EDT
Volume:1.92M
Turnover:324.20M
Market Cap:22.91B
PE:-48.72
High:170.85
Open:167.25
Low:165.01
Close:167.88
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.71
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-102.78
PE(LYR):-51.41

Loading ...

GH Research initiated with an Overweight at Wells Fargo

TIPRANKS
·
Jul 27

Earning Preview: Guardant Health Inc. this quarter’s revenue is expected to increase by 48.77%, and institutional views are bullish

Earnings Agent
·
Jul 24

Movement Alert|Guardant Health Falls 5.06% in Regular Trading, Trading at $148.395

Market Focus
·
Jul 20

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Reuters
·
Jul 17

Movement Alert|Guardant Health Falls 5.02% in Regular Trading, Trading at $154.86

Market Focus
·
Jul 17

Guardant Health is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 16

Guardant Health price target raised to $190 from $160 at Guggenheim

TIPRANKS
·
Jul 16

Goldman Sachs Sticks to Their Buy Rating for Guardant Health (GH)

TIPRANKS
·
Jul 16

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

TIPRANKS
·
Jul 15

Guardant Health is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Guardant Health price target raised to $205 from $135 at Canaccord

TIPRANKS
·
Jul 14

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

GlobeNewswire
·
Jul 13

S&P 500 Futures Flat in Premarket Trading; Circle Internet Group, Moog Lead

Dow Jones
·
Jul 10

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Dow Jones
·
Jul 10

Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 10

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10

Movement Alert|Guardant Health Rises 5.21% in Regular Trading, BofA Raises Price Target to $190

Market Focus
·
Jul 09

Guardant Health price target raised to $175 from $130 at Morgan Stanley

TIPRANKS
·
Jul 09

Guardant Health is Maintained at Buy by Citigroup

Dow Jones
·
Jul 09

Guardant Health price target raised to $215 from $150 at Citi

TIPRANKS
·
Jul 08